
CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER
CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER
Company…

CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc.
CLEARWATER, FLORIDA, UNITED STATES, March 26, 2020 /EINPresswire.com/…

JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer for Phase 2b clinical formulation and development
FOR IMMEDIATE RELEASE
JanOne strikes agreement with CoreRx,…

CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING PRODUCT DEVELOPMENT CAPACITY
CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING…


CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment
Clearwater, Florida, May 14, 2019 — CoreRx, Inc. today announced
that…


CoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI® (Clobazam)
Clearwater, Florida- November 4, 2018 - CoreRx, Inc. announces…

Installation of the Optel Line Master Serialization and Aggregation
Clearwater, Florida – As part of CoreRx, Inc’s growth in…

Bionpharma Signs Drug Product Manufacturing Contract with CoreRx
Bionpharma Signs Drug Product Manufacturing Contract with CoreRx…